These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34887219)

  • 1. Atorvastatin-associated rhabdomyolysis in a patient with a novel variant of the SLCO1B1 gene: A case report.
    Kiage J; Venkatanarayan A; Roth M; Elam M
    J Clin Lipidol; 2022; 16(1):23-27. PubMed ID: 34887219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin.
    Lu B; Sun L; Seraydarian M; Hoffmann TJ; Medina MW; Risch N; Iribarren C; Krauss RM; Oni-Orisan A
    Clin Pharmacol Ther; 2021 Sep; 110(3):733-740. PubMed ID: 34114646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms.
    Linskey DW; English JD; Perry DA; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
    Pharmacogenet Genomics; 2020 Dec; 30(9):208-211. PubMed ID: 32453264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic marker of statin-induced rhabdomyolysis].
    Chiba K; Morimoto K
    Yakugaku Zasshi; 2011 Feb; 131(2):247-53. PubMed ID: 21297370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects.
    Ramakumari N; Indumathi B; Katkam SK; Kutala VK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S120-S125. PubMed ID: 30595243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population.
    Giannakopoulou E; Ragia G; Kolovou V; Tavridou A; Tselepis AD; Elisaf M; Kolovou G; Manolopoulos VG
    Mol Biol Rep; 2014 Jul; 41(7):4631-8. PubMed ID: 24668570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
    Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
    Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control Studies.
    Hou Q; Li S; Li L; Li Y; Sun X; Tian H
    Medicine (Baltimore); 2015 Sep; 94(37):e1268. PubMed ID: 26376374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance.
    Bigossi M; Maroteau C; Dawed AY; Taylor A; Srinivasan S; Melhem AL; Pearson ER; Pola R; Palmer CNA; Siddiqui MK
    Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):536-545. PubMed ID: 37253618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin-induced rhabdomyolysis from azithromycin interaction in a patient with heterozygous SLCO1B1 polymorphism.
    Burns H; Russell L; Cox ZL
    J Clin Pharm Ther; 2021 Jun; 46(3):853-855. PubMed ID: 33277702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink.
    Carr DF; O'Meara H; Jorgensen AL; Campbell J; Hobbs M; McCann G; van Staa T; Pirmohamed M
    Clin Pharmacol Ther; 2013 Dec; 94(6):695-701. PubMed ID: 23942138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research Datalink.
    Carr DF; Francis B; Jorgensen AL; Zhang E; Chinoy H; Heckbert SR; Bis JC; Brody JA; Floyd JS; Psaty BM; Molokhia M; Lapeyre-Mestre M; Conforti A; Alfirevic A; van Staa T; Pirmohamed M
    Clin Pharmacol Ther; 2019 Dec; 106(6):1353-1361. PubMed ID: 31220337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of SLCO1B1 gene polymorphisms and vitamin D on statin-induced myopathy.
    Alghalyini B; El Shamieh S; Salami A; Visvikis Siest S; Fakhoury HM; Fakhoury R
    Drug Metab Pers Ther; 2018 Mar; 33(1):41-47. PubMed ID: 29420305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis.
    Tamraz B; Fukushima H; Wolfe AR; Kaspera R; Totah RA; Floyd JS; Ma B; Chu C; Marciante KD; Heckbert SR; Psaty BM; Kroetz DL; Kwok PY
    Pharmacogenet Genomics; 2013 Jul; 23(7):355-64. PubMed ID: 23652407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.
    Liu JE; Liu XY; Chen S; Zhang Y; Cai LY; Yang M; Lai WH; Ren B; Zhong SL
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1409-1416. PubMed ID: 28812116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLCO1B1 variants and statin-induced myopathy--a genomewide study.
    ; Link E; Parish S; Armitage J; Bowman L; Heath S; Matsuda F; Gut I; Lathrop M; Collins R
    N Engl J Med; 2008 Aug; 359(8):789-99. PubMed ID: 18650507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and statin-related myopathy: what do we know?
    Turner RM; Radman I; Bozina N; Alfirevic A
    Pharmacogenomics; 2020 Aug; 21(12):821-825. PubMed ID: 32723135
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of SLCO1B1 single nucleotide variations and their association with hypercholesterolaemia in hypercholesterolemic patients in Gauteng, South Africa.
    de Beer R; Outhoff K; Phulukdaree A; Soma P
    Xenobiotica; 2021 Aug; 51(8):949-959. PubMed ID: 34154510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia.
    Santos PC; Gagliardi AC; Miname MH; Chacra AP; Santos RD; Krieger JE; Pereira AC
    Eur J Clin Pharmacol; 2012 Mar; 68(3):273-9. PubMed ID: 21928084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of protective haplotypes of the
    Favela-Mendoza AF; Rodríguez-Rodríguez BG; Rojas-Prado E; Chávez-Arreguin M; Aguilar-Velázquez JA; Martínez-Cortés G; Rangel-Villalobos H
    Per Med; 2021 Sep; 18(6):533-540. PubMed ID: 34674552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.